These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12182910)

  • 1. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
    Hainaut P; Jaumotte C; Verhelst D; Wallemacq P; Gala JL; Lavenne E; Heusterspreute M; Zech F; Moriau M
    Thromb Res; 2002 Apr; 106(2):121-5. PubMed ID: 12182910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
    Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
    Hsu TS; Hsu LA; Chang CJ; Sun CF; Ko YL; Kuo CT; Chiang CW; Lee YS
    Thromb Res; 2001 Jun; 102(5):387-95. PubMed ID: 11395124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
    Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
    Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
    Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
    Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.
    Kluijtmans LA; Boers GH; Verbruggen B; Trijbels FJ; Novakova IR; Blom HJ
    Blood; 1998 Mar; 91(6):2015-8. PubMed ID: 9490685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.
    Gemmati D; Previati M; Serino ML; Moratelli S; Guerra S; Capitani S; Forini E; Ballerini G; Scapoli GL
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1761-7. PubMed ID: 10397696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.
    Couturaud F; Oger E; Abalain JH; Chenu E; Guias B; Floch HH; Mercier B; Mottier D; Leroyer C
    Respiration; 2000; 67(6):657-61. PubMed ID: 11124649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
    Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
    Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
    Quéré I; Perneger TV; Zittoun J; Bellet H; Gris JC; Daurès JP; Schved JF; Mercier E; Laroche JP; Dauzat M; Bounameaux H; Janbon C; de Moerloose P
    Lancet; 2002 Mar; 359(9308):747-52. PubMed ID: 11888585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.
    Pezzini A; Del Zotto E; Archetti S; Negrini R; Bani P; Albertini A; Grassi M; Assanelli D; Gasparotti R; Vignolo LA; Magoni M; Padovani A
    Stroke; 2002 Mar; 33(3):664-9. PubMed ID: 11872884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
    Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.